{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Linuron : Questions médicales les plus fréquentes",
"headline": "Linuron : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Linuron : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-10",
"dateModified": "2025-03-05",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Linuron"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Phénylurées",
"url": "https://questionsmedicales.fr/mesh/D010671",
"about": {
"@type": "MedicalCondition",
"name": "Phénylurées",
"code": {
"@type": "MedicalCode",
"code": "D010671",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.455.426.559.389.703"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Linuron",
"alternateName": "Linuron",
"code": {
"@type": "MedicalCode",
"code": "D008044",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Dirk Springael",
"url": "https://questionsmedicales.fr/author/Dirk%20Springael",
"affiliation": {
"@type": "Organization",
"name": "Division of Soil and Water Management, KU Leuven, Leuven, Belgium."
}
},
{
"@type": "Person",
"name": "Başak Öztürk",
"url": "https://questionsmedicales.fr/author/Ba%C5%9Fak%20%C3%96zt%C3%BCrk",
"affiliation": {
"@type": "Organization",
"name": "Division of Soil and Water Management, KU Leuven, Leuven, Belgium."
}
},
{
"@type": "Person",
"name": "Mikael Pedersen",
"url": "https://questionsmedicales.fr/author/Mikael%20Pedersen",
"affiliation": {
"@type": "Organization",
"name": "Research group for Analytical Food Chemistry, National Food Institute, Technical University of Denmark, 2800 Kgs, Lyngby, Denmark."
}
},
{
"@type": "Person",
"name": "Johannes Werner",
"url": "https://questionsmedicales.fr/author/Johannes%20Werner",
"affiliation": {
"@type": "Organization",
"name": "Department of Biological Oceanography, Leibniz Institute for Baltic Sea Research, Rostock, Germany."
}
},
{
"@type": "Person",
"name": "Boyke Bunk",
"url": "https://questionsmedicales.fr/author/Boyke%20Bunk",
"affiliation": {
"@type": "Organization",
"name": "Bioinformatics Department, Leibniz Institute DSMZ, German Collection of Microorganisms and Cell Cultures, Braunschweig, Germany."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Understanding child development and care integrality: Primary Health Care doctors and nurses' view.",
"datePublished": "2024-04-29",
"url": "https://questionsmedicales.fr/article/38695417",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1590/1984-0462/2024/42/2023127"
}
},
{
"@type": "ScholarlyArticle",
"name": "\"The Early Years are Like a Foundation for the Future\" Perspectives, Facilitators, and Challenges of Anganwadi Workers in Supporting Early Child Development Interventions in Hyderabad, India: Qualitative Findings from a Scalable Program Incorporating Early Child Development Interventions.",
"datePublished": "2024-06-29",
"url": "https://questionsmedicales.fr/article/38953808",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.4103/ijph.ijph_868_23"
}
},
{
"@type": "ScholarlyArticle",
"name": "Maternal stimulation and early child development in sub-saharan Africa: evidence from Kenya and Zambia.",
"datePublished": "2023-12-05",
"url": "https://questionsmedicales.fr/article/38053131",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12889-023-17235-w"
}
},
{
"@type": "ScholarlyArticle",
"name": "Adolescent mothers and their children affected by HIV-An exploration of maternal mental health, and child cognitive development.",
"datePublished": "2022-10-20",
"url": "https://questionsmedicales.fr/article/36264898",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1371/journal.pone.0275805"
}
},
{
"@type": "ScholarlyArticle",
"name": "Maternal sleep disturbances during late pregnancy and child neuropsychological and behavioral development in early childhood.",
"datePublished": "2022-08-04",
"url": "https://questionsmedicales.fr/article/35927528",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00787-022-02053-z"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Composés chimiques organiques",
"item": "https://questionsmedicales.fr/mesh/D009930"
},
{
"@type": "ListItem",
"position": 3,
"name": "Hydrocarbures",
"item": "https://questionsmedicales.fr/mesh/D006838"
},
{
"@type": "ListItem",
"position": 4,
"name": "Hydrocarbures cycliques",
"item": "https://questionsmedicales.fr/mesh/D006844"
},
{
"@type": "ListItem",
"position": 5,
"name": "Hydrocarbures aromatiques",
"item": "https://questionsmedicales.fr/mesh/D006841"
},
{
"@type": "ListItem",
"position": 6,
"name": "Dérivés du benzène",
"item": "https://questionsmedicales.fr/mesh/D001555"
},
{
"@type": "ListItem",
"position": 7,
"name": "Phénylurées",
"item": "https://questionsmedicales.fr/mesh/D010671"
},
{
"@type": "ListItem",
"position": 8,
"name": "Linuron",
"item": "https://questionsmedicales.fr/mesh/D008044"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Linuron - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Linuron",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-10",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Linuron",
"description": "Comment diagnostiquer une exposition au linuron ?\nQuels tests peuvent détecter le linuron dans le corps ?\nQuels symptômes indiquent une intoxication au linuron ?\nY a-t-il des tests spécifiques pour les effets du linuron ?\nComment évaluer le risque d'exposition au linuron ?",
"url": "https://questionsmedicales.fr/mesh/D008044?mesh_terms=Child+Development&page=5#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Linuron",
"description": "Quels sont les symptômes d'une exposition aiguë au linuron ?\nPeut-on avoir des effets chroniques après exposition au linuron ?\nQuels signes cliniques sont associés à une intoxication au linuron ?\nComment différencier les symptômes du linuron d'autres toxines ?\nLes symptômes du linuron peuvent-ils varier selon l'âge ?",
"url": "https://questionsmedicales.fr/mesh/D008044?mesh_terms=Child+Development&page=5#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Linuron",
"description": "Comment prévenir l'exposition au linuron ?\nQuelles sont les recommandations pour les travailleurs exposés au linuron ?\nLes femmes enceintes doivent-elles éviter le linuron ?\nQuelles mesures de sécurité doivent être prises lors de l'utilisation du linuron ?\nComment informer le public sur les dangers du linuron ?",
"url": "https://questionsmedicales.fr/mesh/D008044?mesh_terms=Child+Development&page=5#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Linuron",
"description": "Quel traitement est recommandé en cas d'intoxication au linuron ?\nY a-t-il un antidote spécifique pour le linuron ?\nComment traiter les irritations cutanées causées par le linuron ?\nQuels soins d'urgence sont nécessaires en cas d'exposition au linuron ?\nLes traitements varient-ils selon la voie d'exposition au linuron ?",
"url": "https://questionsmedicales.fr/mesh/D008044?mesh_terms=Child+Development&page=5#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Linuron",
"description": "Quelles complications peuvent survenir après une exposition au linuron ?\nLe linuron peut-il affecter la reproduction ?\nY a-t-il des risques de cancer associés au linuron ?\nComment le linuron affecte-t-il le système nerveux ?\nLes enfants sont-ils plus vulnérables aux effets du linuron ?",
"url": "https://questionsmedicales.fr/mesh/D008044?mesh_terms=Child+Development&page=5#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Linuron",
"description": "Quels sont les principaux facteurs de risque d'exposition au linuron ?\nL'environnement peut-il influencer l'exposition au linuron ?\nLes personnes ayant des antécédents médicaux sont-elles à risque ?\nLes conditions de travail affectent-elles le risque d'exposition au linuron ?\nLes habitudes de vie influencent-elles l'exposition au linuron ?",
"url": "https://questionsmedicales.fr/mesh/D008044?mesh_terms=Child+Development&page=5#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une exposition au linuron ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'historique d'exposition et des tests biologiques spécifiques."
}
},
{
"@type": "Question",
"name": "Quels tests peuvent détecter le linuron dans le corps ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des analyses d'urine et de sang peuvent révéler la présence de linuron."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une intoxication au linuron ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des nausées, des vertiges et des irritations cutanées."
}
},
{
"@type": "Question",
"name": "Y a-t-il des tests spécifiques pour les effets du linuron ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de fonction hépatique et rénale peuvent être effectués pour évaluer les effets."
}
},
{
"@type": "Question",
"name": "Comment évaluer le risque d'exposition au linuron ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'évaluation du risque se fait par l'analyse des conditions de travail et des habitudes."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une exposition aiguë au linuron ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes aigus incluent des maux de tête, des nausées et des troubles respiratoires."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des effets chroniques après exposition au linuron ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une exposition prolongée peut entraîner des problèmes respiratoires et dermatologiques."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques sont associés à une intoxication au linuron ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes cliniques incluent des éruptions cutanées, des troubles gastro-intestinaux et des vertiges."
}
},
{
"@type": "Question",
"name": "Comment différencier les symptômes du linuron d'autres toxines ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un historique d'exposition et des tests spécifiques aident à différencier les symptômes."
}
},
{
"@type": "Question",
"name": "Les symptômes du linuron peuvent-ils varier selon l'âge ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les enfants et les personnes âgées peuvent présenter des symptômes plus graves."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'exposition au linuron ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utiliser des équipements de protection individuelle et suivre les protocoles de sécurité."
}
},
{
"@type": "Question",
"name": "Quelles sont les recommandations pour les travailleurs exposés au linuron ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les travailleurs doivent suivre des formations sur la manipulation sécurisée des produits chimiques."
}
},
{
"@type": "Question",
"name": "Les femmes enceintes doivent-elles éviter le linuron ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il est conseillé aux femmes enceintes d'éviter l'exposition au linuron en raison des risques."
}
},
{
"@type": "Question",
"name": "Quelles mesures de sécurité doivent être prises lors de l'utilisation du linuron ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Porter des gants, des masques et travailler dans des zones bien ventilées."
}
},
{
"@type": "Question",
"name": "Comment informer le public sur les dangers du linuron ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des campagnes de sensibilisation et des brochures d'information peuvent être mises en place."
}
},
{
"@type": "Question",
"name": "Quel traitement est recommandé en cas d'intoxication au linuron ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement inclut l'élimination de l'exposition et des soins symptomatiques."
}
},
{
"@type": "Question",
"name": "Y a-t-il un antidote spécifique pour le linuron ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas d'antidote spécifique pour le linuron, le traitement est symptomatique."
}
},
{
"@type": "Question",
"name": "Comment traiter les irritations cutanées causées par le linuron ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les irritations cutanées peuvent être traitées avec des crèmes apaisantes et des antihistaminiques."
}
},
{
"@type": "Question",
"name": "Quels soins d'urgence sont nécessaires en cas d'exposition au linuron ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les soins d'urgence incluent le lavage de la peau et l'administration d'oxygène si nécessaire."
}
},
{
"@type": "Question",
"name": "Les traitements varient-ils selon la voie d'exposition au linuron ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements diffèrent selon qu'il s'agit d'une exposition cutanée, orale ou respiratoire."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir après une exposition au linuron ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des troubles respiratoires chroniques et des problèmes dermatologiques."
}
},
{
"@type": "Question",
"name": "Le linuron peut-il affecter la reproduction ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des études suggèrent que le linuron peut avoir des effets néfastes sur la reproduction."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques de cancer associés au linuron ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des recherches sont en cours pour évaluer le potentiel cancérigène du linuron."
}
},
{
"@type": "Question",
"name": "Comment le linuron affecte-t-il le système nerveux ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une exposition prolongée peut entraîner des troubles neurologiques et des effets cognitifs."
}
},
{
"@type": "Question",
"name": "Les enfants sont-ils plus vulnérables aux effets du linuron ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les enfants peuvent être plus sensibles aux effets toxiques du linuron en raison de leur développement."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque d'exposition au linuron ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les travailleurs agricoles et ceux manipulant des pesticides sont les plus exposés."
}
},
{
"@type": "Question",
"name": "L'environnement peut-il influencer l'exposition au linuron ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la proximité des zones agricoles et l'utilisation de pesticides augmentent le risque."
}
},
{
"@type": "Question",
"name": "Les personnes ayant des antécédents médicaux sont-elles à risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes avec des problèmes respiratoires préexistants peuvent être plus à risque."
}
},
{
"@type": "Question",
"name": "Les conditions de travail affectent-elles le risque d'exposition au linuron ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des conditions de travail non sécurisées augmentent le risque d'exposition au linuron."
}
},
{
"@type": "Question",
"name": "Les habitudes de vie influencent-elles l'exposition au linuron ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des habitudes comme le jardinage sans protection peuvent augmenter l'exposition."
}
}
]
}
]
}
To identify perceptions of primary care health professionals regarding the conceptual aspects of child development and propose strategies to address difficulties....
This descriptive-analytical study was conducted in a small municipality in the countryside of the State of São Paulo, Brazil. The primary health care in this region is comprised of Family Health Units...
Among the participants, 54% were nurses, and the average duration of working with the pediatric population was ten years. 80% reported never having undergone training in child development. The analysi...
The findings underscore the necessity of implementing health education initiatives and service projects in primary care settings. It is crucial to strengthen a comprehensive perspective of child healt...
Integrated Child Development Services (ICDS) scheme, a large public health program, addresses the needs of young children with Anganwadi Workers (AWWs) as frontline agents of delivery. A scalable prog...
This paper describes formative work done with AWWs, as part of ASPIRE to assess their understanding of early childhood development (ECD) and acceptability of a novel ECD intervention using digital tec...
Six focus group discussions (FGDs) were conducted with 31 AWWs, using a semi-structured guide....
Framework analysis of their responses from FGDs led to the identification of three themes: (1) time use, (2) understanding of ECD, and (3) delivering messages using videos. The findings suggest that A...
Integration of novel ECD interventions delivered by frontline workers needs to take into account their existing work schedules and associated challenges. Training on ECD interventions will need to bro...
Despite major improvements in child survival over the past decade, many children in low and middle-income countries (LMICs) remain at risk of not reaching their developmental potential due to malnutri...
We conducted a descriptive study using data from a prospective study in Kenya and Zambia. The study included three rounds of data collection. Children were on average 10 months old in round one, 25 mo...
Higher maternal stimulation scores were associated with higher ASQ scores (effect size = 0.25; 95% CI: 0.19, 0.31) after adjusting for other confounders. For domain specific and child development (ASQ...
Our study findings suggest a strong positive link between maternal stimulation activities and children's developmental outcomes among communities in poor rural settings....
NA (not a clinical trial)....
Some children born to adolescent mothers may have developmental challenges, while others do not. Research focusing on which children of adolescent mothers are at the highest risk for cognitive delay i...
Cross-sectional data utilised within the analyses was drawn from a large cohort of adolescent mothers and their children residing in South Africa. Detailed study questionnaires were completed by adole...
The study included 954 adolescent mothers; 24.1% (230/954) were living with HIV, 12.6% (120/954) were classified as experiencing likely common mental disorder. After adjusting for covariates, maternal...
This study addresses a critical evidence gap relating to the understanding of possible risk factors for the cognitive development of children born to adolescent mothers affected by HIV. This group of ...
The present study aims to explore the association of maternal sleep disturbances during late pregnancy on child neuropsychological and behavioral development in preschool years. The study included 638...
Inequity in child development is found at early age, but limited evidence exists on whether these gaps change over time and what are the mediators....
We aim to (1) quantify wealth related gaps in cognitive and socio-emotional development in early and middle childhood; (2) examine how these gaps were mitigated by maternal, child factors and home env...
We assessed the offspring of women who participated in a randomized controlled trial of preconception micronutrient supplementation in Vietnam (n = 1599). Child development was measured by the Bayley ...
We found significant wealth gaps in cognitive development during early childhood (gaps between top and bottom quintiles: 0.5 SD); these gaps increased substantially in middle childhood (0.9 SD). Wealt...
Interventions focusing on improving quality of home environment, maternal education, wellbeing, and child nutrition status may help reduce developmental deficits associated with poverty....
Recent studies have reported the effect of neonicotinoid (NEO) exposures on development in human. However, information about the risk of childhood development delays due to NEO exposures is limited....
The study aimed to examine the association between NEO exposure and child development up to 4 years of age using data of the Japan Environment and Children's Study....
The study employed urinary NEO and metabolite concentrations in the first and second or third trimesters; the Japanese translation of the Ages and Stages Questionnaire (third edition; J-ASQ-3) scores ...
The determination rates of urinary acetamiprid-N-desmethyl (dm-ACE), clothianidin (CLO), dinotefuran (DIN) and thiamethoxam (THX) were greater than 50%. Median urinary dm-ACE, CLO, DIN and THX concent...
To identify and describe distinct trajectories of cognitive and socioemotional development during childhood and to examine their relationships with adolescent health....
We used group-based multitrajectory modeling applied to longitudinal data on 11 564 children up to age 14 years from the UK Millennium Cohort study to identify trajectories of cognitive and socioemoti...
Four child development trajectories were identified: "no problems" (76.5%); "late socio-emotional problems" (10.1%); "early cognitive and socioemotional problems" (8.6%); and "persistent cognitive and...
In a representative UK cohort, groups of distinct trajectories of cognitive and socioemotional development were identified. Adverse development, if unresolved, can have a negative impact on weight and...
Most studies on the effect of intimate partner violence (IPV) do not distinguish between the effects of the different types of IPVs on the various aspects of child development....
This study explores the effect of multiple dimensions of IPV, specifically physical violence, controlling behavior, and emotional abuse, on children's physical and cognitive development....
The study uses data from the Cebu Longitudinal Health and Nutritional Survey (CLHNS). The study uses a final sample of n = 1506 index children in Cebu, Philippines....
We use information pertaining to: (1) presence of IPV in the household, (2) demographic characteristics, (3) mother's status and autonomy, (4) anthropometric data, and (5) children's scores on mathema...
Maternal exposure to physical violence significantly reduces child's body mass index (BMI) (ATE: -0.344, p ≤ 0.05). On the other hand, mother's vulnerability to controlling behavior decreases children...
Our study shows that the deleterious effect of IPV on child development is IPV-specific. Exposure to physical violence tends to affect children's physical development while cognitive abilities are neg...
The rising cesarean birth rate globally has led to increasing concern about long-term unintended consequences, with particular focus on child neurodevelopmental outcomes. This study investigated the a...
This was a large multicenter longitudinal prospective cohort study of first-time mothers and their offspring in Pennsylvania. Mothers completed adapted versions of two measures of child development at...
There were 695 (29.3%) children born by cesarean delivery and 1676 (70.7) born vaginally. Children born by cesarean had increased odds of scoring as developmentally delayed on both measures of child d...
In this large prospective cohort study of first-time mothers and their offspring, cesarean delivery was found to be associated with an elevated risk of delayed child development at age 3 years. This a...